People in the News

Premium

Sequenom has appointed Charles Slacik to its board of directors. Slacik has served as chief financial officer and senior vice president of finance for Beckman Coulter since 2006. Previously, he was executive vice president and chief financial officer at Watson Pharmaceuticals, a specialty pharmaceutical company; and senior vice president and chief financial officer at CR Bard, which develops medical technologies in the fields of vascular, urology, oncology, and surgical specialty products.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.